Position in GRAL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,402,861
-$1,628,000 QoQ
Shares Held
46,495
-1.3% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 19.627916980320464.ToString("F0")%
Shared 0.ToString("F0")%
None 80.37208301967954.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,138,138,827 across 32 Diagnostics & Research names. GRAL ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
611,950 | $300,791,783 | |
| 2 | DHR |
Danaher Corp /De/
|
1,012,199 | $191,912,930 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
173,731 | $97,617,711 | |
| 4 | ILMN |
Illumina, Inc.
|
609,802 | $75,164,194 | |
| 5 | A |
Agilent Technologies, Inc.
|
499,389 | $56,920,358 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
324,104 | $55,272,696 | |
| 7 | WAT |
Waters Corp /De/
|
178,037 | $53,019,418 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
42,022 | $52,998,146 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,402,861 | 46,495 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,030,861 | 47,095 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,870,170 | 48,540 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,539,582 | 49,389 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $645,344 | 25,268 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $455,871 | 25,539 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $365,107 | 26,534 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $445,115 | 28,960 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||